The global debate over the high cost of drugs reaches Geneva this month, when the governing body of the World Health Organization (WHO) will consider two proposals aimed at reshaping the forces that drive medical research and development.
by Kenya and Brazil, and calls on the agency to consider measures that would boost the development of new drugs. The reform movement stems from a growing concern about the lack of treatments, vaccines and diagnostic products for diseases that affect developing countries. 
